Evelyn Kuhnt

Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis

Frank M. Brunkhorst, Christoph Engel, Frank Bloos et al. · New England Journal of Medicine · 2008 · 2.9K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +16

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Lorenz Trümper, Anders Österborg et al. · The Lancet Oncology · 2006 · 2.1K citations

Medicine, Oncology, Chemotherapy +11

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper et al. · The Lancet Oncology · 2011 · 811 citations

Medicine, Oncology, Pharmacotherapy +13

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20⁺B-Cell Lymphoma in the Rituximab Era

Marita Ziepert, Dirk Hasenclever, Evelyn Kuhnt et al. · Journal of Clinical Oncology · 2010 · 585 citations · Full text

Medicine, Immunology, Oncology +13

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

Michael Pfreundschuh, Anthony D. Ho, Eva Cavallin‐Ståhl et al. · The Lancet Oncology · 2008 · 223 citations

Medicine, Oncology, Pharmacotherapy +11